Literature DB >> 20524317

Acute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.

Linda J Stuckey1, Malek Kamoun, Anish Wadhwa, Millie Samaniego, Cathy Bartos, Jennifer Berry, Raja Mahidhara, Andrew C Chang, Kevin M Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20524317

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


× No keyword cloud information.
  1 in total

1.  Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?

Authors:  Tetsuya Tajima; Koichiro Hata; Hideaki Okajima; Momoko Nishikori; Kentaro Yasuchika; Jiro Kusakabe; Atsushi Yoshizawa; Ken Fukumitsu; Takayuki Anazawa; Hirokazu Tanaka; Seidai Wada; Junshi Doi; Akifumi Takaori-Kondo; Shinji Uemoto
Journal:  Transplant Direct       Date:  2019-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.